These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37100501)

  • 41. Artificial Intelligence for Hip Fracture Detection and Outcome Prediction: A Systematic Review and Meta-analysis.
    Lex JR; Di Michele J; Koucheki R; Pincus D; Whyne C; Ravi B
    JAMA Netw Open; 2023 Mar; 6(3):e233391. PubMed ID: 36930153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing and validating a multivariable prediction model to improve the diagnostic accuracy in determination of cervical versus endometrial origin of uterine adenocarcinomas: A prospective MR study combining diffusion-weighted imaging and spectroscopy.
    Lin G; Lin YC; Wu RC; Yang LY; Lu HY; Tsai SY; Huang YT; Huang YL; Lu KY; Ng KK; Yen TC; Chao A; Lai CH; Hong JH
    J Magn Reson Imaging; 2018 Jun; 47(6):1654-1666. PubMed ID: 29178414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
    Penson RT; Huang HQ; Wenzel LB; Monk BJ; Stockman S; Long HJ; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Method M; Michael H; Tewari KS
    Lancet Oncol; 2015 Mar; 16(3):301-11. PubMed ID: 25638326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction models applying machine learning to oral cavity cancer outcomes: A systematic review.
    Adeoye J; Tan JY; Choi SW; Thomson P
    Int J Med Inform; 2021 Oct; 154():104557. PubMed ID: 34455119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy for metastatic and recurrent cervical cancer.
    Scatchard K; Forrest JL; Flubacher M; Cornes P; Williams C
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006469. PubMed ID: 23076924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI-derived radiomics analysis improves the noninvasive pretreatment identification of multimodality therapy candidates with early-stage cervical cancer.
    Li Y; Ren J; Yang JJ; Cao Y; Xia C; Lee EYP; Chen B; Guan H; Qi YF; Gao X; Tang W; Chen K; Jin ZY; He YL; Xiang Y; Xue HD
    Eur Radiol; 2022 Jun; 32(6):3985-3995. PubMed ID: 35018480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
    Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
    Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
    Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
    [No Abstract]   [Full Text] [Related]  

  • 51. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively.
    Li Z; Li H; Wang S; Dong D; Yin F; Chen A; Wang S; Zhao G; Fang M; Tian J; Wu S; Wang H
    J Magn Reson Imaging; 2019 May; 49(5):1420-1426. PubMed ID: 30362652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
    BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
    Liu S; Li R; Liu Q; Sun D; Yang H; Pan H; Wang L; Song S
    Cancer Biomark; 2022; 33(2):249-259. PubMed ID: 35213357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
    Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
    Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
    Frumovitz M; Obermair A; Coleman RL; Pareja R; Lopez A; Ribero R; Isla D; Rendon G; Bernardini MQ; Buda A; Moretti-Marquez R; Zevallos A; Vieira MA; Zhu T; Land RP; Nicklin J; Asher R; Robledo KP; Gebski V; Ramirez PT
    Lancet Oncol; 2020 Jun; 21(6):851-860. PubMed ID: 32502445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
    Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
    Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application and Clinical Value of Machine Learning-Based Cervical Cancer Diagnosis and Prediction Model in Adjuvant Chemotherapy for Cervical Cancer: A Single-Center, Controlled, Non-Arbitrary Size Case-Control Study.
    Wang Y; Shen L; Jin J; Wang G
    Contrast Media Mol Imaging; 2022; 2022():2432291. PubMed ID: 35821886
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.